Zengliang Wang

897 citations
45 papers · 550 indexed · h-index 14
Topics
Intracranial Aneurysms: Treatment and Complications (6 papers)Cancer-related molecular mechanisms research (6 papers)Circular RNAs in diseases (6 papers)
Partner nations
ChinaGermanyKazakhstan

In The Last Decade

Zengliang Wang

40 papers receiving 540 citations

Peers

Zengliang Wang
Comparison fields: 5 of 82
  • Molecular Biology 232
  • Cancer Research 174
  • Surgery 111
  • Pulmonary and Respiratory Medicine 88
  • Epidemiology 84
Replace Yilin Yu with:
Yilin Yu China
Sooyeon Lee Germany
Yuanxin Zhu China
Shuqiang Li China
Samuel Bennett Australia
Pang-ning Teng United States
Satoko Sunamura Japan
Susan McCormick United States
Zengliang Wang relative to Yilin Yu China Yilin Yu's profile →
Citations per field
00.5×3.4×
Yilin Yu · 1×
Citations per year

Countries citing papers authored by Zengliang Wang

Since Specialization
Citations

This map shows the geographic impact of Zengliang Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zengliang Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zengliang Wang more than expected).

Fields of papers citing papers by Zengliang Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zengliang Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zengliang Wang. The network helps show where Zengliang Wang may publish in the future.

Co-authorship network of co-authors of Zengliang Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Zengliang Wang. A scholar is included among the top collaborators of Zengliang Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zengliang Wang. Zengliang Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 0
3 1
4 13
5 6
6 11
7 2
8 73
9 2
10 8
11 1
12 17
13 8
14 1
15 16
16 9
17 24
18 1
19 1
20 16

About Zengliang Wang

Zengliang Wang is a scholar working on Cancer Research, Internal Medicine and Genetics, having authored 45 papers that have together received 550 indexed citations. Recurring topics across this work include Intracranial Aneurysms: Treatment and Complications (6 papers), Cancer-related molecular mechanisms research (6 papers) and Circular RNAs in diseases (6 papers). The work is most often cited by research in Cancer Research (174 citations), Orthopedics and Sports Medicine (50 citations) and Molecular Biology (232 citations). Zengliang Wang has collaborated with scholars based in China, Germany and Kazakhstan. Frequent co-authors include Aierpati Maimaiti, Qin Hu, Wang Jia, Yanxia Jiang, Li Zhao, Peng Zhang, Jia‐Guo Zhao, Qin Hu, Pengfei Wu and Yun Wang. Their work appears in journals such as SHILAP Revista de lepidopterología, Biochemical and Biophysical Research Communications and Frontiers in Immunology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026